Evorpacept (ALX148)

evorpacept · ALX Oncology Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Evorpacept (ALX148), covering 2024-11-27 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) [Phase 2, Phase 3]